iPSC-Based Disease Modeling and Drug Screening: An Interview with Paul Tesar and Matthew Elitt

被引:0
|
作者
Tesar, Paul
Elitt, Matthew
机构
来源
STEM CELL REPORTS | 2018年 / 11卷 / 03期
关键词
D O I
10.1016/j.stemcr.2018.08.020
中图分类号
Q813 [细胞工程];
学科分类号
摘要
This month we present a new Q&A with Paul Tesar, DPhil, Associate Professor and Director of the Pluripotent Stem Cell Facility at Case Western Reserve University (U.S.). Dr. Tesar is a recipient of the Beddington Medal of the British Society for Developmental Biology and the 2015 recipient of the ISSCR's Young Investigator Award. Stem Cell Reports has invited Dr. Tesar and graduate student Matthew Elitt, the first author of Elitt et al. (in this issue of Stem Cell Reports), to answer some questions about their publication and share perspective and insights on their research and mentoring the next generation of scientists.
引用
收藏
页码:613 / 615
页数:3
相关论文
共 50 条
  • [1] iPSC-based drug screening for Huntington's disease
    Zhang, Ningzhe
    Bailus, Barbara J.
    Ring, Karen L.
    Ellerby, Lisa M.
    BRAIN RESEARCH, 2016, 1638 : 42 - 56
  • [2] iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
    Okano, Hideyuki
    Morimoto, Satoru
    CELL STEM CELL, 2022, 29 (02) : 189 - 208
  • [3] iPSC-based modeling of Parkinson's disease
    Raya, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A13 - A13
  • [4] Human iPSC-based retinal cell library for disease modeling and drug discovery
    Reichman, Sacha
    Nanteau, Celine
    Clemencon, Marilou
    Lechuga, Marc
    Guillonneau, Xavier
    Sahel, Jose-Alain
    Goureau, Olivier
    Gozlan, Sandy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [5] Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
    Anurag Mathur
    Peter Loskill
    Kaifeng Shao
    Nathaniel Huebsch
    SoonGweon Hong
    Sivan G. Marcus
    Natalie Marks
    Mohammad Mandegar
    Bruce R. Conklin
    Luke P. Lee
    Kevin E. Healy
    Scientific Reports, 5
  • [6] Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
    Mathur, Anurag
    Loskill, Peter
    Shao, Kaifeng
    Huebsch, Nathaniel
    Hong, SoonGweon
    Marcus, Sivan G.
    Marks, Natalie
    Mandegar, Mohammad
    Conklin, Bruce R.
    Lee, Luke P.
    Healy, Kevin E.
    SCIENTIFIC REPORTS, 2015, 5
  • [7] Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease
    Pasteuning-Vuhman, Svetlana
    de Jongh, Rianne
    Timmers, Annabel
    Pasterkamp, R. Jeroen
    TRENDS IN MOLECULAR MEDICINE, 2021, 27 (03) : 263 - 279
  • [8] iPSC-based model of Vogt-Koyanagi-Harada disease for phenotype recapitulation and drug screening
    Li, Wanqian
    Tan, Jun
    He, Siyuan
    Yue, Yingying
    Liu, Huan
    Li, Ruonan
    Wang, Xiaotang
    Wang, Guoqing
    Fan, Wei
    Zhao, Chenyang
    Zhou, Qian
    Yang, Peizeng
    Hou, Shengping
    CLINICAL IMMUNOLOGY, 2023, 246
  • [9] iPSC-Based Modeling of SCA12 for Targeted Therapeutic Screening
    Roy, R.
    Reddy, B.
    Gerutshang, A.
    Banerjee, R.
    Chowdhury, S.
    Kumar, H.
    Chattarji, S.
    MOVEMENT DISORDERS, 2024, 39 : S594 - S594
  • [10] Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications
    Doss, Michael Xavier
    Sachinidis, Agapios
    CELLS, 2019, 8 (05)